Registered entities
THERAVANCE BIOPHARMA, INC.
Reg. No. 1583107United States
THERAVANCE BIOPHARMA US, INC.
Reg. No. 001t000000hjeInAAIUnited States
Theravance Biopharma US, Inc.
Reg. No. 98-1226628United States
THERAVANCE BIOPHARMA U.S., INC.
Reg. No. 463451245United States
Innovation
19 patent families (6 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 177 times.
| Year | Filings |
|---|---|
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 6 |
| 2017 | 6 |
| 2018 | 7 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 4 |
| 2025 | 1 |
Social engagement
Social engagement: 8.8K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
8 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 63% |
| Private equity | 1 | 13% |
| Other / undisclosed | 2 | 25% |
Recent activity
13 Jan 2026
Recognition
10 Nov 2025
Event
Q3 2025 Financial Results and Business Update
7 Nov 2025
Event
AAS 2025